Correlation Engine 2.0
Clear Search sequence regions


  • 6 an (1)
  • breast cancer (1)
  • breast neoplasms (1)
  • CCL2 (1)
  • G6PD (7)
  • humans (1)
  • IL 10 (1)
  • macrophage (8)
  • phosphate (1)
  • protein human (1)
  • switzerland (1)
  • TAMs (1)
  • tgf β1 (1)
  • Sizes of these terms reflect their relevance to your search.

    Glucose-6-phosphate dehydrogenase (G6PD) is involved in triple-negative breast cancer (TNBC) progression. Metabolic crosstalk between cancer cells and tumor-associated macrophages mediates tumor progression in TNBC. Molecular biological methods were applied to clarify the mechanism of the crosstalk between TNBC cells and M2 macrophages. In the present study, we verified that G6PD overexpression drives M2 macrophage polarization by directly combining with phospho-STAT1 and upregulating CCL2 and TGF-β1 secretion in TNBC cells. In turn, M2-like TAMs activated TNBC cells through IL-10 secretion, providing feedback to upregulate G6PD and promote TNBC cell migration and proliferation in vitro. Furthermore, we found that 6-AN (a specific inhibitor of G6PD) not only suppressed the cancer-driven polarization of macrophages toward the M2 phenotype but also inhibited the inherent M2 polarization of macrophages. Targeting the G6PD-regulated pentose phosphate pathway restrained TNBC progression and M2-type polarization of macrophages in vitro and in vivo. © 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

    Citation

    Yin Li, Xiao Han, Zhoujun Lin, Changjun Wang, Zhenkun Fu, Qiang Sun, Chenggang Li. G6PD activation in TNBC cells induces macrophage recruitment and M2 polarization to promote tumor progression. Cellular and molecular life sciences : CMLS. 2023 May 27;80(6):165

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 37237244

    View Full Text